Cargando…
Research progress on effects of traditional Chinese medicine on myocardial ischemia–reperfusion injury: A review
Ischemic heart disease (IHD) is a high-risk disease in the middle-aged and elderly population. The ischemic heart may be further damaged after reperfusion therapy with percutaneous coronary intervention (PCI) and other methods, namely, myocardial ischemia–reperfusion injury (MIRI), which further aff...
Autores principales: | Xing, Na, Long, Xiao-Tong, Zhang, Hui-Juan, Fu, Li-Dan, Huang, Jian-Yuan, Chaurembo, Abdallah Iddy, Chanda, Francis, Xu, Yun-Jing, Shu, Chi, Lin, Kai-Xuan, Yang, Ke, Lin, Han-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763941/ https://www.ncbi.nlm.nih.gov/pubmed/36561346 http://dx.doi.org/10.3389/fphar.2022.1055248 |
Ejemplares similares
-
Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism
por: Zheng, Ting, et al.
Publicado: (2023) -
Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases
por: Cheng, Xiuli, et al.
Publicado: (2022) -
Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3
por: Zhou, Lin, et al.
Publicado: (2022) -
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021) -
Potential application of traditional Chinese medicine in cerebral ischemia—Focusing on ferroptosis
por: Zhao, Fengyan, et al.
Publicado: (2022)